Ledger.Open graph →
SEC Form D · filed August 9, 2017

Resonant Therapeutics, Inc

Offering
$2.6M
Sold
$1.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SANTA BARBARA, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (3)

Jim Fleming · Chantilly, VAExec · DirectorJoshua Bederman · New York, NYExec · DirectorJohn K. Westwick · Santa Barbara, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗